All in all, our study identifies neuronal APOE4 as a strong driver of many important AD pathologies and demonstrates that it has a potent effect on promoting tau pathology, gliosis and accumulation of disease-associated glial subpopulations and subsequent degenerative phenotypes. The gene discussed is MAPT; the disease is Alzheimer disease.